NCT01925521 - OPS-2071 Single and Multiple Dose Study to Investigate PK and PD Profile in Healthy Korean Male Subjects. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

April 30, 2014

Conditions

Healthy

Interventions

DRUG

Part1 : OPS-2071

single oral dose under fasted condition

DRUG

Part1 : Placebo of OPS-2071

single oral dose under fasted condition

DRUG

Part2 : OPS-2071

multiple twice-daily oral dosing for 5-7days

DRUG

Part2 : Placebo of OPS-2071

multiple twice-daily oral dosing for 5-7days

Trial Locations (1)

Seoul National University Hospital, Seoul